203 related articles for article (PubMed ID: 17327416)
1. Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation.
Ciceri F; Bonini C; Marktel S; Zappone E; Servida P; Bernardi M; Pescarollo A; Bondanza A; Peccatori J; Rossini S; Magnani Z; Salomoni M; Benati C; Ponzoni M; Callegaro L; Corradini P; Bregni M; Traversari C; Bordignon C
Blood; 2007 Jun; 109(11):4698-707. PubMed ID: 17327416
[TBL] [Abstract][Full Text] [Related]
2. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.
Munshi NC; Govindarajan R; Drake R; Ding LM; Iyer R; Saylors R; Kornbluth J; Marcus S; Chiang Y; Ennist D; Kwak L; Reynolds C; Tricot G; Barlogie B
Blood; 1997 Feb; 89(4):1334-40. PubMed ID: 9028956
[TBL] [Abstract][Full Text] [Related]
3. The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies.
Traversari C; Marktel S; Magnani Z; Mangia P; Russo V; Ciceri F; Bonini C; Bordignon C
Blood; 2007 Jun; 109(11):4708-15. PubMed ID: 17327417
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
[TBL] [Abstract][Full Text] [Related]
5. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.
Bonini C; Ferrari G; Verzeletti S; Servida P; Zappone E; Ruggieri L; Ponzoni M; Rossini S; Mavilio F; Traversari C; Bordignon C
Science; 1997 Jun; 276(5319):1719-24. PubMed ID: 9180086
[TBL] [Abstract][Full Text] [Related]
6. Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.
Hashimoto H; Kitano S; Ueda R; Ito A; Tada K; Fuji S; Yamashita T; Tomura D; Nukaya I; Mineno J; Fukuda T; Mori S; Takaue Y; Heike Y
Int J Hematol; 2015 Jul; 102(1):101-10. PubMed ID: 25948083
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions.
Burt RK; Drobyski WR; Seregina T; Traynor A; Oyama Y; Keever-Taylor C; Stefka J; Kuzel TM; Brush M; Rodriquez J; Burns W; Tennant L; Link C
Exp Hematol; 2003 Oct; 31(10):903-10. PubMed ID: 14550806
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors.
Verzeletti S; Bonini C; Marktel S; Nobili N; Ciceri F; Traversari C; Bordignon C
Hum Gene Ther; 1998 Oct; 9(15):2243-51. PubMed ID: 9794208
[TBL] [Abstract][Full Text] [Related]
9. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.
Bondanza A; Valtolina V; Magnani Z; Ponzoni M; Fleischhauer K; Bonyhadi M; Traversari C; Sanvito F; Toma S; Radrizzani M; La Seta-Catamancio S; Ciceri F; Bordignon C; Bonini C
Blood; 2006 Mar; 107(5):1828-36. PubMed ID: 16293601
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
[TBL] [Abstract][Full Text] [Related]
11. Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft-versus-leukemia reaction?
Gallot G; Hallet MM; Gaschet J; Moreau JF; Vivien R; Bonneville M; Milpied N; Vié H
Blood; 1996 Aug; 88(3):1098-103. PubMed ID: 8704220
[TBL] [Abstract][Full Text] [Related]
12. Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation.
Hashimoto H; Kitano S; Yamagata S; Miyagi Maeshima A; Ueda R; Ito A; Tada K; Fuji S; Yamashita T; Tomura D; Nukaya I; Mineno J; Fukuda T; Mori S; Takaue Y; Heike Y
Cytotherapy; 2015 Dec; 17(12):1820-30. PubMed ID: 26452983
[TBL] [Abstract][Full Text] [Related]
13. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?
Tiberghien P; Reynolds CW; Keller J; Spence S; Deschaseaux M; Certoux JM; Contassot E; Murphy WJ; Lyons R; Chiang Y
Blood; 1994 Aug; 84(4):1333-41. PubMed ID: 8049449
[TBL] [Abstract][Full Text] [Related]
14. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
[TBL] [Abstract][Full Text] [Related]
15. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.
Bordignon C; Bonini C; Verzeletti S; Nobili N; Maggioni D; Traversari C; Giavazzi R; Servida P; Zappone E; Benazzi E
Hum Gene Ther; 1995 Jun; 6(6):813-9. PubMed ID: 7548281
[TBL] [Abstract][Full Text] [Related]
16. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.
Tiberghien P; Ferrand C; Lioure B; Milpied N; Angonin R; Deconinck E; Certoux JM; Robinet E; Saas P; Petracca B; Juttner C; Reynolds CW; Longo DL; Hervé P; Cahn JY
Blood; 2001 Jan; 97(1):63-72. PubMed ID: 11133743
[TBL] [Abstract][Full Text] [Related]
17. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation.
Marktel S; Magnani Z; Ciceri F; Cazzaniga S; Riddell SR; Traversari C; Bordignon C; Bonini C
Blood; 2003 Feb; 101(4):1290-8. PubMed ID: 12393508
[TBL] [Abstract][Full Text] [Related]
18. Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft.
Deschamps M; Mercier-Lethondal P; Certoux JM; Henry C; Lioure B; Pagneux C; Cahn JY; Deconinck E; Robinet E; Tiberghien P; Ferrand C
Blood; 2007 Dec; 110(12):3842-52. PubMed ID: 17717134
[TBL] [Abstract][Full Text] [Related]
19. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting.
Contassot E; Ferrand C; Angonin R; Cohen JL; de Carvalho Bittencourt M; Lorchel F; Laithier V; Cahn JY; Klatzmann D; Herve P; Tiberghien P
Transplantation; 2000 Feb; 69(4):503-8. PubMed ID: 10708102
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.
Litvinova E; Maury S; Boyer O; Bruel S; Benard L; Boisserie G; Klatzmann D; Cohen JL
Blood; 2002 Sep; 100(6):2020-5. PubMed ID: 12200361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
